Clinical Trials Browser

Phase 2 × Unknown × hetrombopag × Clear all

NCT06099925 2023-10-25

The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies

Phase 2 Unknown

Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT06036966 2023-09-14

The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients

Phase 2 Unknown

Classical hematology

Thrombocytopenia